Letrozole Improves Breast Cancer Survival (HealthDay)
29th Dec 2005, 02:40 GMT
HealthDay - WEDNESDAY, Dec. 28 (HealthDay News) -- Postmenopausal breast cancer patients who take letrozole, one of a new class of drugs called aromatase inhibitors, reduce their risk of cancer recurrence compared with women taking tamoxifen, a breast cancer drug used widely for more than two decades, researchers report.
Letrozole Improves Breast Cancer Survival (HealthDay) related news:
- Letrozole Improves Breast Cancer Survival (HealthDay) —
- Letrozole Improves Breast Cancer Survival — MedicineNet Daily News
- ORIGINAL ARTICLE: A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer — New England Journal of Medicine
- Letrozole tops tamoxifen for early breast cancer (Reuters) — Yahoo! News: Health News
- Letrozole tops tamoxifen for early breast cancer — Reuters: Health
- Breast Cancer Survivors Bounce Back Quickly (HealthDay) — Yahoo! News: Health News
- Femara Helps More Women Live Breast Cancer-Free — RedOrbit News - Health
- New breast cancer drug 21 percent as effective as tamoxifen in preventing relapse — The Earth Times Online Newspaper
- Study Sees Benefit in High-Dose Chemotherapy for Breast Cancer (American Cancer Society) — Yahoo! Health: Breast Cancer News
- Letrozole Better Than Tamoxifen In Reducing Risk Of Recurrence For Breast Cancer Survivors, IBSCG Study Published In NEJM — Medical News Today RSS/XML Feed
Latest news from Yahoo! News: Health News:
- Health care costs could jump 10 percent (AP)
- Results mixed on Merck's new painkiller (AP)
- More South Africans get AIDS medicine (AP)
- Europe to draw up strategy against obesity (AFP)
- Clinical Trials Update: Nov. 13, 2006 (HealthDay)
- Pharmacy Program Helps Elderly Take Their Meds (HealthDay)
- Red meat may raise breast cancer risk (AP)
- Insurers' plan aims to cover uninsured (AP)
- FDA: Tamiflu patients need monitoring (AP)
- Flu Drug Tamiflu May Cause Odd Behavior in Children (HealthDay)